Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
Int J Mol Sci. 2019 Nov 15;20(22):5748. doi: 10.3390/ijms20225748.
Protozoan diseases continue to be a worldwide social and economic health problem. Increased drug resistance, emerging cross resistance, and lack of new drugs with novel mechanisms of action significantly reduce the effectiveness of current antiprotozoal therapies. While drug resistance associated to anti-infective agents is a reality, society seems to remain unaware of its proportions and consequences. Parasites usually develops ingenious and innovative mechanisms to achieve drug resistance, which requires more research and investment to fight it. In this review, drug resistance developed by protozoan parasites , and will be discussed.
原生动物病仍然是一个全球性的社会和经济健康问题。药物耐药性的增加、新的交叉耐药性以及缺乏具有新作用机制的新药,显著降低了现有抗原生动物疗法的效果。虽然与抗感染药物相关的耐药性是一个现实,但社会似乎仍然没有意识到其程度和后果。寄生虫通常会发展出巧妙和创新的耐药机制,这需要更多的研究和投资来对抗。在这篇综述中,将讨论原生动物寄生虫的耐药性发展。